Functional Imaging of Cerebral Blood Flow and Glucose Metabolism in Parkinson’s Disease and Huntington’s Disease

被引:0
作者
Yilong Ma
David Eidelberg
机构
[1] New York University School of Medicine,Center for Neurosciences, Feinstein Institute for Medical Research, North Shore–Long Island Jewish Health System
[2] New York University School of Medicine,Department of Neurology
[3] New York University School of Medicine,Department of Medicine
来源
Molecular Imaging and Biology | 2007年 / 9卷
关键词
Neurodegenerative disorders; Parkinson’s disease; Huntington’s disease; Cerebral blood flow; Metabolism; Brain mapping; Spatial covariance analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Brain imaging of cerebral blood flow and glucose metabolism has been playing key roles in describing pathophysiology of Parkinson’s disease (PD) and Huntington’s disease (HD), respectively. Many biomarkers have been developed in recent years to investigate the abnormality in molecular substrate, track the time course of disease progression, and evaluate the efficacy of novel experimental therapeutics. A growing body of literature has emerged on neurobiology of these two movement disorders in resting states and in response to brain activation tasks. In this paper, we review the latest applications of these approaches in patients and normal volunteers at rest conditions. The discussions focus on brain mapping studies with univariate and multivariate statistical analyses on a voxel basis. In particular, we present data to validate the reproducibility and reliability of unique spatial covariance patterns related with PD and HD.
引用
收藏
页码:223 / 233
页数:10
相关论文
共 445 条
[1]  
Worsley KJ(1997)Characterizing the response of PET and fMRI data using multivariate linear models NeuroImage 6 305-319
[2]  
Poline JB(1996)Detecting activations in PET and fMRI: levels of inference and power NeuroImage 4 223-235
[3]  
Friston KJ(2003)Multivariate analysis of neuronal interactions in the generalized partial least squares framework: simulations and empirical studies NeuroImage 20 625-642
[4]  
Evans AC(1994)Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: a principal component approach to modeling brain function in disease Hum Brain Mapp 2 1-16
[5]  
Friston KJ(1994)The metabolic topography of parkinsonism J Cereb Blood Flow Metab 14 783-801
[6]  
Holmes A(2003)Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging Hum Brain Mapp 18 13-21
[7]  
Poline JB(2001)Metabolic correlates of levodopa response in Parkinson’s disease Neurology 57 2083-2088
[8]  
Price CJ(2002)Primary dystonia: is abnormal functional brain architecture linked to genotype? Ann Neurol 52 853-856
[9]  
Frith CD(2004)Covariance PET patterns in early Alzheimer’s disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance NeuroImage 23 35-45
[10]  
Lin FH(2005)Neuroimaging and therapeutics in movement disorders NeuroRx 2 361-371